Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 19 of 19 publications.

Levintow SN, Reading SR, Noshad S, Mayer SE, Wiener C, Eledath B, Exter J, Brookhart MA. Lipid testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019. Clin Epidemiol. 2022 Jun 1;2022(14):737-48. doi: 10.2147/CLEP.S361258

Mayer SE, Edwards JK, Lund JL, Hallas J, Sturmer T. Modeling drug treatment effects on breast cancer in the setting of differential screening. Poster presented at the Virtual ICPE 2021 Conference; August 2021. [abstract] Pharmacoepidemiol Drug Saf. 2021 Aug 23; 30(S1). doi: 0.1002/pds.5305

Mayer S, McGrath LJ, Kim M, McDermott M, Brookhart MA. Prevalence of osteoporosis and its treatment among women≥50 inNHANES: 1999-2018. Poster presented at the Virtual ICPE 2021 Conference; August 2021. [abstract] Pharmacoepidemiol Drug Saf. 2021 Aug; 30(Suppl 1):28. doi: 10.1002/pds.5305

Mayer SE, Edwards JK, Hallas J, Lund JL, Sturmer LT. Modeling cancer risk following drug initiation under various screening regimens: a discrete event simulation. Poster presented at the 2021 Virtual Society of Epidemiologic Research Annual Meeting; June 22, 2021.

Mayer S, Edwards JK, Stumer ET. The impact of differential screening in studies of medication use and cancer risk. Poster presented at the 2020 Virtual Society of Epidemiologic Research Annual Meeting; December 2020.

Mayer S, Edwards JK, Lund JL, Stürmer T. Differential cancer screening during follow-up as a source of bias in pharmacoepidemiology. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020. Berlin, Germany.

Reeder-Hayes KE, Mayer SE, Olshan AF, Wheeler SB, Carey LA, Tse CK, Bell ME, Troester MA. Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study. Cancer. 2019 Nov 15;125(22):3985-92. doi: 10.1002/cncr.32378

Mayer SE, Pate V, Nichols HB, Lund JL, Reeder-Hayes KE. Use of ovarian suppression with endocrine therapy among premenopausal women with breast cancer in the United States, 2001-2016. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 24; 28(Suppl 2).

Mayer SE, Weiss NS, Chubak J, Doody DR, Carlson CS, Makar KW, Wurscher MA, Malone KE. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes Control. 2019 Jan;30(1):103-12. doi: 10.1007/s10552-018-1117-x

Mayer SE, Pate V, Hanson LC, Jonsson Funk M, Faurot KR, Stumer T, Lund JL. Improving claims-based frailty prediction in the Medicare population using STOPPFrail drug criteria. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug 17; 27(52):193. doi: 10.1002/pds.4629

Newcomb PA, Adams SV, Mayer S, Passarelli MN, Tinker L, Lane D, Chlebowski RT, Crandall C. Postmenopausal fracture history and survival after reproductive cancer diagnosis. JNCI Cancer Spect. 2018 Jan;2(1). doi: 10.1093/jncics/pky001

Mayer S, Reeder-Hayes KE, Tse CK, Olshan AF, Troester MA. Treatment delay in black and white women in the Carolina Breast Cancer Study. Poster presented at the 2017 Annual Lineberger Comprehensive Cancer Center Scientific Retreat; October 10, 2017. Chapel Hill, NC.

Mayer SE, Troester M, Wheeler SB, Olshan A, Carey LA, Tse J, Reeder-Hayes KE. Temporal patterns of breast cancer treatment initiation and completion among black and white women in the Carolina Breast Cancer Study. Presented at the 2017 10th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25, 2017. Atlanta, GA.

Mayer S. Temporal patterns of breast cancer treatment initiation and completion among black and white women in the carolina breast cancer study. Poster presented at the 10th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25, 2017. Atlanta, GA.

Mayer SE, Tan HJ, Peacock Hinton S, Hester LL, Sturmer T, Faurot KR, Jonsson Funk M, Sanoff HK, Lund JL. Medicare claims-based measures of poor physical function and associations with treatment and mortality in older colon cancer patients. Poster presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug 22; 26(Suppl 2):174. doi: 10.1002/pds.4275

Mayer S, Weiss NS, Chubak J, Doody DR, Malone KE. CYP2D6-inhibiting medication use and inherited variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Poster presented at the 2017 50th Society of Epidemiologic Research Annual Meeting; June 20, 2017. Seattle, WA.